Joe Pierre summarises two recently published and widely reported RCTs, which suggest that antipsychotic medication might not offer an advantage over psychotherapy in broadly-defined first episode psychosis.
[read the full story...]
André Tomlin appraises a new RCT published today of virtual reality CBT versus waiting list control for paranoid ideation and social avoidance in people with psychosis.
[read the full story...]
Lisa Wood publishes her debut blog about a recent RCT of social recovery therapy in combination with early intervention services for enhancement of social recovery in patients with first-episode psychosis: the SUPEREDEN3 trial.
[read the full story...]
Jack Barton publishes his debut elf blog on the huge OASIS randomised controlled trial, which explores the effects that improved sleep can have on our mental health.
[read the full story...]
Clive Adams presents a summary of the latest evidence for CBTp and medication in the treatment of psychosis. This blog was published alongside Clive’s talk at the Understanding Psychosis and Schizophrenia conference in Bath on 11 June 2015
[read the full story...]
People with schizophrenia stop taking their antipsychotics for a wide range of reasons (e.g. debilitating side effects or a belief that they will not help them), but when they do health professionals often find it extremely difficult to care for these patients, because the alternative treatment options available to them are very limited. Of course, [read the full story…]
Early intervention services for psychosis are aimed at people aged 14-35 who are experiencing a first episode of psychosis or at risk of doing so. The teams that work in this area usually include psychiatrists, psychologists, community psychiatric nurses, social workers and support workers. The NICE schizophrenia guideline recommends that early intervention services are offered [read the full story…]
Antipsychotic drugs are currently prescribed to a significant proportion of young people who are diagnosed with psychosis. Past research has estimated that up to half of people at risk of developing psychosis at a young age will progress to a full blown psychotic illness such as schizophrenia. A new landmark randomised controlled trial has been [read the full story…]
